Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0018 | 0.1152 | 0.0792 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0023 | 0.2775 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0016 | 0.0391 | 0.0612 |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.0015 | 0 | 0.5 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0022 | 0.2223 | 0.1906 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.2775 | 1 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Toxoplasma gondii | exonuclease III APE | 0.0022 | 0.2223 | 0.5 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0022 | 0.2223 | 0.3477 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0045 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0022 | 0.2223 | 1 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0022 | 0.2223 | 1 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Schistosoma mansoni | ap endonuclease | 0.0022 | 0.2223 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0022 | 0.2223 | 0.5 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0022 | 0.2223 | 0.2223 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0016 | 0.0391 | 0.0391 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0391 | 0.0612 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Leishmania major | DNA polymerase kappa, putative | 0.0023 | 0.2775 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0022 | 0.2223 | 0.1906 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0045 | 1 | 1 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0022 | 0.2223 | 0.7682 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0022 | 0.2223 | 0.5 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Echinococcus multilocularis | dna polymerase kappa | 0.0045 | 1 | 1 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.2775 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0038 | 0.7616 | 0.7519 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0034 | 0.6393 | 0.6246 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0016 | 0.0391 | 0.1761 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.6393 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0018 | 0.1152 | 0.0792 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0016 | 0.0391 | 0.0391 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Mycobacterium ulcerans | DNA polymerase IV | 0.0045 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0018 | 0.1152 | 0.0792 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0045 | 1 | 1 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0016 | 0.0391 | 0.1761 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0022 | 0.2223 | 0.5 |
Trypanosoma brucei | unspecified product | 0.0038 | 0.7616 | 0.7519 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Mycobacterium ulcerans | DNA polymerase IV | 0.0045 | 1 | 1 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0045 | 1 | 1 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0016 | 0.0391 | 0.0612 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0022 | 0.2223 | 0.3477 |
Echinococcus granulosus | dna polymerase eta | 0.0016 | 0.0391 | 0.0391 |
Brugia malayi | polk-prov protein | 0.0034 | 0.6393 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0034 | 0.6393 | 0.6246 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0022 | 0.2223 | 0.5 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0022 | 0.2223 | 0.7682 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0022 | 0.2223 | 0.2223 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.2775 | 0.2481 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0022 | 0.2223 | 0.1906 |
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.0015 | 0 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0016 | 0.0391 | 0.0612 |
Echinococcus multilocularis | dna polymerase eta | 0.0016 | 0.0391 | 0.0391 |
Schistosoma mansoni | DNA polymerase eta | 0.0016 | 0.0391 | 0.1761 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.